<!doctype html>
<html lang="en">
<head>
  <!-- hreflang pair -->
  <link rel="alternate" hreflang="en" href="https://briefrooms.com/en/health/cholesterol.html" />
  <link rel="alternate" hreflang="pl" href="https://briefrooms.com/pl/zdrowie/cholesterol.html" />
  <link rel="alternate" hreflang="x-default" href="https://briefrooms.com/" />

  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width,initial-scale=1" />
  <title>Your cholesterol & full lipid panel — a practical guide | BriefRooms</title>
  <meta name="description" content="How to read LDL, HDL, TG, non-HDL, Remnant-C/RC, TG/HDL, and what really improves the numbers. Evidence-based, practical steps (ESC/EAS, ACC/AHA, AHA/WHO, EFSA)." />
  <link rel="icon" href="/assets/favicon.svg" />
  <link rel="stylesheet" href="/assets/site.css" />
  <style>
    :root{ --line:rgba(255,255,255,.08); --muted:#a8b3c7; --muted2:#b9c5d8 }
    header{ padding:32px 16px 18px; text-align:center }
    h1{ margin:0 0 8px; font-size:clamp(26px,4.8vw,40px) }
    .lead{ margin:0; color:var(--muted) }
    main{ max-width:1060px; margin:26px auto 80px; padding:0 16px }
    .card{
      background:linear-gradient(180deg,rgba(255,255,255,.06),rgba(255,255,255,.02));
      border:1px solid var(--line); border-radius:20px; padding:22px;
      box-shadow:0 16px 44px -18px rgba(0,0,0,.35), inset 0 0 0 1px rgba(255,255,255,.03);
      margin-bottom:18px;
    }
    h2{ margin:6px 0 12px; font-size:clamp(20px,3.6vw,26px) }
    h3{ margin:18px 0 10px; font-size:clamp(18px,2.8vw,22px) }
    p{ margin:10px 0 12px }
    ul{ margin:8px 0 12px 20px } li{ margin:6px 0 }
    .pill{ display:inline-block; padding:4px 10px; border-radius:999px; background:#0f1a28; border:1px solid var(--line); color:var(--muted2); font-size:13px; white-space:nowrap }
    .wrap{ background:rgba(255,255,255,.03); border:1px solid var(--line); border-radius:12px; padding:14px }
    .cols{ display:grid; grid-template-columns:1fr; gap:16px }
    @media (min-width:780px){ .cols{ grid-template-columns:1fr 1fr } }
    .sources li a{ color:#b9c5d8; text-decoration:none } .sources li a:hover{ color:#c7d2e3; text-decoration:underline }
    .back{ margin-top:12px } .back a{ color:#a8c8ff; text-decoration:none } .back a:hover{ text-decoration:underline }
    footer{ text-align:center; opacity:.55; padding:6px 16px 36px; font-size:14px }

    /* 3D transparent chips using <details> (no JS) */
    .chips{ display:flex; flex-wrap:wrap; gap:10px; margin:10px 0 6px }
    details.pop{
      position:relative; border-radius:12px; border:1px solid var(--line);
      background:linear-gradient(180deg,rgba(255,255,255,.04),rgba(255,255,255,.02));
      box-shadow:0 10px 24px rgba(0,0,0,.25), inset 0 0 0 1px rgba(255,255,255,.03);
      padding:8px 12px; cursor:pointer; transition:.15s ease;
    }
    details.pop:hover{ filter:brightness(1.04) }
    details.pop summary{ list-style:none; outline:none }
    details.pop summary::-webkit-details-marker{ display:none }
  details.pop .popover{
  position:absolute; left:0; top:calc(100% + 8px); min-width:260px; max-width:320px;
  border-radius:12px; 
  border:1px solid rgba(255,255,255,.14);
  background:linear-gradient(180deg, rgba(64,110,84,.98), rgba(38,79,60,.98)); /* ciepło-zielone tło */
  color:#f3fff6; /* jaśniejszy tekst dla kontrastu */
  box-shadow:0 18px 42px rgba(0,0,0,.45), inset 0 0 0 1px rgba(255,255,255,.06);
  padding:12px 14px; font-size:13px; z-index:5;
}

    details.pop[open] .popover{ animation:pop .12s ease-out }
    @keyframes pop{ from{ transform:translateY(-4px); opacity:0 } to{ transform:none; opacity:1 } }

    /* small text inside popovers */
    .small{ font-size:12px; opacity:.95; line-height:1.45 }

    /* spacing helpers */
    .mb0{ margin-bottom:0 }
  </style>
</head>
<body>
  <header>
    <h1>Your cholesterol & full lipid panel — a practical guide</h1>
    <p class="lead">Below you’ll find the essence of how to read your results, what truly improves them, and how to implement changes in 5 steps — based on aligned guidelines (ESC/EAS, ACC/AHA), AHA/WHO statements, EFSA reviews and reviews on remnant cholesterol (e.g., <span class="pill">PMC</span>).</p>
  </header>

  <main>
    <article class="card">
      <section>
        <h2>Your lipid panel, without jargon</h2>
        <ul>
          <li><strong>LDL-C</strong> — the “bad” cholesterol and main driver of atherosclerosis. Lower is better. For a generally healthy adult (final targets depend on clinical risk and your doctor): roughly good &lt; <strong>100 mg/dL</strong>, needs work <strong>100–159</strong>, high/poor <strong>≥160</strong>. <span class="pill">ESC/EAS</span></li>
          <li><strong>HDL-C</strong> — the “good” one. Too low: &lt;<strong>40</strong> mg/dL (men), &lt;<strong>50</strong> mg/dL (women). We don’t “chase” very high HDL with pills — the whole profile matters. <span class="pill">ACC</span></li>
          <li><strong>TG</strong> (triglycerides) — fats circulating in blood. Good &lt;<strong>150</strong> mg/dL; borderline/high <strong>150–499</strong>; very high <strong>≥500</strong> (pancreatitis risk → urgent management). <span class="pill">ACC</span></li>
          <li><strong>TC</strong> (total cholesterol) — use as supportive only; LDL-C and the indices below are more informative. <span class="pill">ESC/EAS</span></li>
        </ul>

        <h3>Two extremely useful indices you can calculate yourself</h3>
        <ul>
          <li><strong>non-HDL-C = TC − HDL-C.</strong> Captures all atherogenic particles (LDL + remnants). Roughly: good &lt;<strong>130</strong>; needs work <strong>130–159</strong>; high/poor <strong>≥160</strong>. (Guidelines: the non-HDL target is ~30 mg/dL higher than the matching LDL target.) <span class="pill">ScienceDirect</span></li>
          <li><strong>Remnant-C (remnant cholesterol) = TC − LDL-C − HDL-C</strong> (or non-HDL − LDL). Higher is worse; &gt;<strong>20–25</strong> mg/dL often flags residual risk to tackle via diet/activity and TG control. <span class="pill">PMC</span></li>
          <li><strong>RC (residual cholesterol):</strong> used similarly to Remnant-C in literature; elevated RC suggests atherogenic remnant overload even when LDL looks “okay”. <span class="pill">PMC</span></li>
          <li><strong>TG/HDL ratio:</strong> a practical insulin-resistance proxy; higher ratios track cardiometabolic risk (interpret together with TG, HDL and clinical context). <span class="pill">PMC</span></li>
        </ul>
      </section>

      <section class="wrap">
        <h2>Why this matters</h2>
        <p>It’s not only correlation: LDL-C <em>causes</em> atherosclerosis — confirmed by genetics, observational cohorts and hundreds of randomized trials. Lowering LDL reduces MI/stroke risk, and long-term exposure to high LDL accumulates lifetime risk. Remnants add risk even with “decent” LDL. <span class="pill">PMC</span></p>
      </section>

      <section>
        <h2>What works best — simple, effective, no gimmicks</h2>

        <h3>1) Food: change the <em>type</em> of fat, not just “eat less fat”</h3>

        <div class="chips">
          <!-- SFA chip -->
          <details class="pop">
            <summary>Saturated fats</summary>
            <div class="popover">
              <div class="small">
                <strong>SFA</strong> most abundant in: fatty cuts of red meat, full-fat cheese, butter/cream, palm/coconut fats.
                Focus on swapping SFA <em>out</em> rather than adding “superfoods”.
              </div>
            </div>
          </details>

          <!-- UFA chip -->
          <details class="pop">
            <summary>Unsaturated fats</summary>
            <div class="popover">
              <div class="small">
                <strong>MUFA</strong> (olive, canola/rapeseed, high-oleic oils, nuts) and <strong>PUFA</strong> (soy/sunflower/linseed oils, walnuts, fatty fish). Replacing SFA with MUFA/PUFA lowers LDL and ASCVD risk.
              </div>
            </div>
          </details>

          <!-- Canola oil note -->
          <details class="pop">
            <summary>Canola oil (MUFA)</summary>
            <div class="popover">
              <div class="small">
                In short: claims that “seed oils cause inflammation” aren’t supported by solid reviews or guidelines — swapping SFA for unsaturated fats (canola/olive/soy) lowers LDL and CVD risk, and higher omega-6 intake alone doesn’t raise inflammatory markers. <span class="pill">AHA</span> <span class="pill">ACC</span><br><br>
                Regulatory view: the EU renewed glyphosate approval to 15-Dec-2033 with pre-harvest desiccation ban; FAO/WHO monitoring shows residues largely within legal limits. Glyphosate is highly polar and remains mainly in meal; studies did not detect it in cold-pressed rapeseed oil. Historical erucic-acid issues relate to old cultivars; modern low-erucic varieties comply with strict limits. <span class="pill">EC</span> <span class="pill">FAO/WHO</span> <span class="pill">PMC</span> <span class="pill">EFSA</span>
              </div>
            </div>
          </details>
        </div>

        <p class="mb0"><strong>What to prioritise (everyday pattern):</strong></p>
        <ul>
          <li>Olive oil, canola/rapeseed oil (mostly MUFA); linseed/soy/sunflower oils (PUFA) used reasonably in cooking.</li>
          <li>Nuts & seeds (almonds, walnuts, flax, sesame) as snack swaps for sweets/processed snacks.</li>
          <li>Fish <strong>2×/week</strong> (salmon, mackerel, herring, sardines).</li>
          <li>Plenty of vegetables/legumes/whole grains — a Mediterranean-style, minimally processed pattern.</li>
          <li>Limit: fatty processed meats, full-fat cheeses/butter, ultra-processed sweets and refined carbs.</li>
        </ul>

        <p class="wrap"><strong>5.1 Evidence note:</strong> studies (e.g., Mensink RP, <em>Am J Clin Nutr</em> 2016) show that replacing <strong>5% of energy from SFA</strong> with unsaturated fats lowers <strong>LDL by ≈10%</strong> with no harm to HDL. <span class="pill">AHA</span></p>

        <h3>2) Soluble (gel-forming) fibre — daily, from concrete sources</h3>
        <ul>
          <li>≈<strong>3 g/day</strong> β-glucan from oats/barley lowers LDL by ~5–7%. Psyllium (5–10 g/day) similar. <span class="pill">EFSA</span> <span class="pill">PMC</span></li>
          <li>Best sources: oats/bran, barley, psyllium husk, legumes (lentils/beans/chickpeas).</li>
        </ul>

        <h3>3) Phytosterols — in foods + optional fortified products</h3>
        <ul>
          <li><strong>1.5–2.4 g/day</strong> lowers LDL ~7–10%. Rich foods: vegetable oils (sesame/rice bran/corn/canola), sesame, sunflower, wheat germ; fortified spreads/yogurts help reach 2 g/d. <span class="pill">EFSA</span> <span class="pill">NCBI</span></li>
        </ul>

        <h3>4) Activity “by the watch”</h3>
        <ul>
          <li><strong>150–300 min/week</strong> moderate or <strong>75–150 min</strong> vigorous + <strong>2×</strong> strength: TG ↓, HDL ↑, sometimes LDL ↓; consistency is key. <span class="pill">WHO</span></li>
        </ul>

        <h3>5) High-impact basics</h3>
        <ul>
          <li>Weight ↓ (if excess): strongest effect on TG and non-HDL-C. <span class="pill">ACC</span></li>
          <li>Alcohol & simple sugars ↓: fastest way to lower TG. <span class="pill">ACC</span></li>
          <li>Stop smoking: HDL improves and overall risk drops. <span class="pill">AHA</span></li>
          <li>Exclude secondary causes (e.g., hypothyroidism, some meds). <span class="pill">ESC/EAS</span></li>
        </ul>
      </section>

      <section class="wrap">
        <h2>How to use this — a 5-step mini-procedure</h2>
        <ol>
          <li>Write down four numbers: <strong>TC, LDL-C, HDL-C, TG</strong>.</li>
          <li>Compute: <strong>non-HDL-C = TC − HDL-C</strong>; <strong>Remnant-C = TC − LDL-C − HDL-C</strong>.</li>
          <li>Traffic-light check (healthy adult, no known high risk): LDL-C &lt;100 good, 100–159 needs work, ≥160 poor; non-HDL-C &lt;130 good, 130–159 needs work, ≥160 poor; TG &lt;150 good, 150–499 needs work, ≥500 very high; HDL-C low if &lt;40 (men) / &lt;50 (women). <span class="pill">ESC/EAS</span> <span class="pill">ACC</span></li>
          <li>Implement: Mediterranean pattern + SFA→UFA swap + daily soluble fibre + WHO activity + alcohol/sugar cut-back.</li>
          <li>Re-check in 6–12 weeks. If not green: talk to your clinician about next steps (e.g., ezetimibe/statins/PCSK9 as per guidelines and risk).</li>
        </ol>
      </section>

      <section>
        <h2>Sources & further reading</h2>
        <ul class="sources">
          <li><a href="https://www.portailvasculaire.fr/" target="_blank" rel="noopener">ESC/EAS 2019 dyslipidaemia guidelines (overview of LDL/non-HDL/ApoB, non-fasting sampling)</a></li>
          <li><a href="https://www.ahajournals.org/" target="_blank" rel="noopener">AHA scientific statements on dietary fats & eating patterns</a></li>
          <li><a href="https://professional.heart.org/" target="_blank" rel="noopener">AHA — smoking cessation & CVD risk</a></li>
          <li><a href="https://www.acc.org/" target="_blank" rel="noopener">ACC/AHA — triglycerides thresholds and management</a></li>
          <li><a href="https://www.who.int/" target="_blank" rel="noopener">WHO — physical activity guidelines for adults</a></li>
          <li><a href="https://www.efsa.europa.eu/" target="_blank" rel="noopener">EFSA — β-glucan/psyllium & phytosterols opinions</a></li>
          <li><a href="https://pubmed.ncbi.nlm.nih.gov/" target="_blank" rel="noopener">PMC — remnant cholesterol & cardiometabolic risk</a></li>
        </ul>
        <p class="back">← <a href="/en/health.html">Back to Health</a></p>
      </section>
    </article>
  </main>

  <footer>© BriefRooms</footer>
</body>
</html>
